For pharmaceutical and medical device companies, keeping a product within its required temperature range from origin to destination is not a logistical nicety. It is a matter of patient safety and regulatory compliance. A single break in the cold chain can render a shipment of vaccines, biologics, or temperature-sensitive medications ineffective and unusable. Understanding how temperature is maintained in transit, and the two fundamental approaches to doing it, helps shippers make better decisions about protecting high-value healthcare products.
Why the Cold Chain Matters
The pharmaceutical cold chain exists because many medicines are only stable within specific temperature ranges. Regulatory frameworks like Good Distribution Practice, established by authorities including the FDA, set expectations for how temperature-sensitive products are stored and moved.
While every product has its own requirements stated on its labeling, the industry generally works within a few recognized ranges. Controlled room temperature is typically defined as 20°C to 25°C. Refrigerated, the most common cold chain range, covers 2°C to 8°C and applies to most vaccines and biologics. Frozen generally runs from around -10°C to -30°C depending on the product, and ultra-cold or cryogenic ranges, used for certain mRNA vaccines and advanced cell and gene therapies, extend well below that. Because terminology varies between regions, the safest practice is always to work from the exact temperature range specified for the product rather than a general label.
When a product moves outside its required range, even briefly, it is called a temperature excursion. Depending on the product and the severity, an excursion can mean the affected stock has to be quarantined, investigated, and in some cases destroyed. That is the risk the cold chain is built to prevent, and it is why Jade International treats temperature-sensitive cargo as a category requiring specific equipment and handling rather than standard freight.
The Two Approaches: Active and Passive
There are two fundamental ways to hold a shipment at temperature in transit: active systems and passive systems. They are not competitors so much as different tools suited to different shipments, and many supply chains use both. Jade’s pharmaceutical transport services use both active refrigeration and passive packaging, matched to the shipment.
Active temperature control uses powered equipment to maintain temperature, functioning much like the HVAC system in a building or the refrigeration unit on a reefer trailer. An active system actively cools and, where needed, heats to hold a set point, adjusting as conditions change. Because it is powered and self-regulating, active control offers precise, consistent temperature management over long durations. This is the approach behind refrigerated containers and refrigerated trucking. For readers who want the mechanics of how a powered refrigeration unit works, our post on reefer trucking walks through the refrigeration cycle in detail.
Passive temperature control uses no power at all. Instead, it relies on insulated packaging combined with a coolant such as dry ice, gel packs, or phase change material to hold temperature for a defined period. A passive shipper is essentially a highly engineered insulated container: it protects its contents for a set number of hours or days based on the packaging and coolant used, with no active regulation. Passive systems are simpler and often more economical for smaller shipments or shorter transit windows, though they hold temperature only for a limited duration before the coolant is exhausted.
How to Choose Between Them
The right approach depends on the specifics of the shipment. The risk profile of the product usually drives the decision, along with a few practical factors:
- Shipment duration. Passive systems protect for a fixed window. For long international transit times, active systems provide temperature control that does not run out partway through the journey.
- Shipment size. Passive packaging suits smaller parcels and cartons. Larger, pallet-scale, or bulk pharmaceutical shipments often call for active refrigerated equipment.
- Product value and risk. For high-value biologics where an excursion means a total loss, the precision and consistency of active control can justify the higher cost.
- Temperature range required. The tighter and more extreme the required range, the more likely an active or specialized solution is needed.
For many shipments, the answer involves both. A pharmaceutical shipment might travel in an active refrigerated container for its main transport legs and rely on passive packaging for shorter segments, with the two working together to keep the cold chain unbroken end to end.
Keeping the Chain Unbroken Across Every Leg
The most important principle in cold chain logistics is that the chain is only as strong as its weakest link. A shipment held perfectly at temperature during its ocean or air leg can still fail during a port handoff, a customs hold, or the final inland delivery if temperature control lapses at any of those points. This is why coordinating the full journey under one provider matters. Jade International connects air and ocean freight with refrigerated domestic trucking and temperature-controlled warehousing, reducing the handoffs where the cold chain is most likely to break.
For pharmaceutical importers, the cold chain also intersects with regulatory compliance. Temperature-sensitive drugs and biologics regulated by the FDA carry their own import requirements, including Prior Notice filing before arrival, which have to be managed alongside the temperature controls so cargo is not left sitting while paperwork is resolved.
Jade International provides temperature-controlled logistics for pharmaceuticals and medical devices, combining active refrigeration and passive packaging with medical-grade warehousing and stability verification at transit points. If you are moving temperature-sensitive healthcare products and want a partner who manages the cold chain across every leg, reach out to our team.
